Simplex Trading’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-700
| Closed | -$6.73K | – | 8982 |
|
|
2025
Q4 | $6.73K | Buy |
+700
| New | +$6.7K | ﹤0.01% | 7249 |
|
|
2025
Q2 | – | Sell |
-1,000
| Closed | -$15K | – | 8552 |
|
|
2025
Q1 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 6780 |
|
|
2024
Q4 | $16K | Buy |
+1,000
| New | +$19.7K | ﹤0.01% | 6838 |
|
|
2024
Q2 | – | Sell |
-100
| Closed | -$2K | – | 8702 |
|
|
2024
Q1 | $2K | Buy |
+100
| New | +$2.42K | ﹤0.01% | 8352 |
|
|
2023
Q3 | – | Sell |
-2,800
| Closed | -$72K | – | 8578 |
|
|
2023
Q2 | $72K | Sell |
2,800
-200
| -7% | -$5.35K | ﹤0.01% | 5449 |
|
|
2023
Q1 | $86K | Buy |
+3,000
| New | +$89.3K | ﹤0.01% | 5311 |
|
|
2022
Q3 | – | Sell |
-1,100
| Closed | -$24K | – | 9829 |
|
|
2022
Q2 | $24K | Buy |
1,100
+900
| +450% | +$20.1K | ﹤0.01% | 7373 |
|
|
2022
Q1 | $5K | Buy |
+200
| New | +$6.1K | ﹤0.01% | 9380 |
|
|
2021
Q4 | – | Sell |
-600
| Closed | -$26K | – | 10398 |
|
|
2021
Q3 | $26K | Hold |
600
| – | – | ﹤0.01% | 8188 |
|
|
2021
Q2 | $25K | Buy |
600
+448
| +295% | +$19.1K | ﹤0.01% | 8370 |
|
|
2021
Q1 | $620K | Buy |
152
+59
| +63% | +$2.24K | ﹤0.01% | 3054 |
|
|
2020
Q4 | $420K | Sell |
93
-408
| -81% | -$15.5K | ﹤0.01% | 3649 |
|
|
2020
Q3 | $1.77M | Buy |
501
+375
| +298% | +$13.5K | ﹤0.01% | 1651 |
|
|
2020
Q2 | $475K | Buy |
126
+93
| +282% | +$3.06K | ﹤0.01% | 2975 |
|
|
2020
Q1 | $95K | Buy |
33
+31
| +1,550% | +$1.25K | ﹤0.01% | 4419 |
|
|
2019
Q4 | $10K | Sell |
2
-95
| -98% | -$5.52K | ﹤0.01% | 6363 |
|
|
2019
Q3 | $532K | Buy |
97
+56
| +137% | +$2.88K | ﹤0.01% | 2553 |
|
|
2019
Q2 | $166K | Sell |
41
-26
| -39% | -$948 | ﹤0.01% | 3658 |
|
|
2019
Q1 | $202K | Buy |
+67
| New | +$2.29K | ﹤0.01% | 3599 |
|
|
2018
Q4 | – | Sell |
-112
| Closed | -$472K | – | 6932 |
|
|
2018
Q3 | $472K | Buy |
112
+27
| +32% | +$1.07K | ﹤0.01% | 2691 |
|
|
2018
Q2 | $272K | Buy |
+85
| New | +$3.5K | ﹤0.01% | 3126 |
|
|
2017
Q4 | – | Sell |
-26
| Closed | -$5K | – | 5922 |
|
|
2017
Q3 | $5K | Sell |
26
-193
| -88% | -$10.1K | ﹤0.01% | 4338 |
|
|
2017
Q2 | $204K | Buy |
219
+187
| +584% | +$8.61K | 0.01% | 1186 |
|
|
2017
Q1 | $1K | Sell |
32
-14
| -30% | -$668 | ﹤0.01% | 5530 |
|
|
2016
Q4 | $3K | Sell |
46
-6
| -12% | -$277 | ﹤0.01% | 4682 |
|
|
2016
Q3 | $2K | Buy |
+52
| New | +$2.57K | ﹤0.01% | 4869 |
|
|
2015
Q2 | – | Sell |
-14
| Closed | -$2K | – | 5120 |
|
|
2015
Q1 | $2K | Buy |
+14
| New | +$566 | ﹤0.01% | 4035 |
|
Other funds holding ANIK
CP
BFM
CM
Simplex Trading's ANIK Position: Q2 2026 in Review
Simplex Trading sold out of Anika Therapeutics (ANIK) in Q2 2026, closing a stake of 70 shares — an estimated $1.01K sold.
Simplex Trading first reported a position in ANIK in Q4 2014 and held it in 24 quarters. The position peaked at $343K in Q3 2017. 134 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.
- Simplex Trading reported no remaining Anika Therapeutics position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 70 Anika Therapeutics shares in Q2 2026, an estimated $1.01K.
- Simplex Trading first reported a position in Anika Therapeutics in Q4 2014 and held it in 24 quarters.
- Simplex Trading's Anika Therapeutics position peaked at $343K in Q3 2017.
- 134 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.